صرف نظر و مشاهده محتوا
· Biorevitalisation
SKU 11211

Viscoderm 1.6

In stock
Volume
3 x 1,5 mL
Laboratory
IBSA
Origin
ایتالیا
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, developed to counteract moderate xerodermia associated with dermatitis and/or psoriasis. It is administered intradermally by qualified personnel. The highly purified sodium hyaluronate comes from fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1.5 ml pre-filled syringe holds 24 mg, equivalent to 16 mg/ml.

مزایای اصلی Viscoderm 1.6

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for moderate xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
اطلاعات کلیدی
برند Viscoderm
سازنده IBSA
کشور سازنده Italy
گواهینامه CE-marked medical device for intradermal use, CE 0477
ترکیبات Per 1.5 ml syringe: sodium hyaluronate 24.000 mg; sodium chloride 12.750 mg; sodium phosphate 0.307 mg; water for injection q.s. 1.5 ml
حجم / اندازه 1.5 ml per syringe, 4.5 ml per pack
بسته‌بندی 3 pre-filled syringes x 1.5 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
اندازه سوزن 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
نوع کاربرد Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
عمق تزریق Intradermal, at medium-deep level, using a linear or picotage technique
پروتکل / مدت Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

موارد مصرف و استفاده حرفه‌ای

موارد مصرف اصلی

  • Moderate xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

استفاده حرفه‌ای

Viscoderm 1.6 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Because the 1.5 ml pre-filled syringe allows a whole session to be completed with a single syringe, it is advisable to replace the needle halfway through the treatment, for example using two separate needles to treat the whole face. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

نواحی درمان

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

مشخصات بیمار

Viscoderm 1.6 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 1.6% concentration is indicated to counteract moderate xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

نحوه عملکرد Viscoderm 1.6 ​

Viscoderm 1.6 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 1.6% concentration is the mid concentration of the three in the range and is the one indicated for moderate xerodermia.

چرا از Allpara سفارش دهید

Allpara محصولات VISCODERM اصل و تأییدشده را از تأمین‌کنندگان منتخب، با قابلیت ردیابی کامل سری ساخت و پشتیبانی تخصصی ارائه می‌دهد. ما به کلینیک‌ها و متخصصان زیبایی با محصولات دارای گواهی CE، ارسال سریع به سراسر اتحادیه اروپا از انبار ما در اتحادیه اروپا و قیمت‌های رقابتی حرفه‌ای خدمت می‌کنیم. تمرکز ما بر ایمنی، رضایت و نتایج بیماران شماست - همراه با پشتیبانی اختصاصی پس از فروش برای آسودگی خاطر شما.

پرسش‌های متداول

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

محصولات بیشتر از IBSA

View laboratory

Clinic alternatives

All products

Viscoderm 1.6

In stock
Verified-only pricing
Sign in or apply for a B2B account to see your price.
Apply for B2B

Viscoderm 1.6 is a sterile, single-use injectable hyaluronic acid medical device by IBSA, developed to counteract moderate xerodermia associated with dermatitis and/or psoriasis. It is administered intradermally by qualified personnel. The highly purified sodium hyaluronate comes from fermentation, is not chemically modified and has a molecular weight of approximately 1 million Dalton, close to that of endogenous hyaluronic acid. Each 1.5 ml pre-filled syringe holds 24 mg, equivalent to 16 mg/ml.

مزایای اصلی Viscoderm 1.6

  • Highly purified hyaluronic acid obtained by fermentation
  • Not chemically modified
  • Molecular weight of approximately 1 million Dalton
  • Supports restoration of physiological hyaluronic acid levels in treated tissue
  • Supports tissue rehydration
  • Helps create favourable conditions for tissue remodelling
  • Indicated for moderate xerodermia associated with dermatitis and/or psoriasis
  • High biocompatibility and excellent tolerability
  • Sterile, pyrogen-free and single-use
اطلاعات کلیدی
برند Viscoderm
سازنده IBSA
کشور سازنده Italy
گواهینامه CE-marked medical device for intradermal use, CE 0477
ترکیبات Per 1.5 ml syringe: sodium hyaluronate 24.000 mg; sodium chloride 12.750 mg; sodium phosphate 0.307 mg; water for injection q.s. 1.5 ml
حجم / اندازه 1.5 ml per syringe, 4.5 ml per pack
بسته‌بندی 3 pre-filled syringes x 1.5 ml, with 6 needles 30G x 1/2 inch (0.3 x 12 mm)
اندازه سوزن 30G x 1/2 inch (0.3 x 12 mm), 6 needles supplied per pack
نوع کاربرد Professional use only, by qualified practitioners. Sterile and apyrogenic, single use.
عمق تزریق Intradermal, at medium-deep level, using a linear or picotage technique
پروتکل / مدت Initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Shelf life 36 months.

موارد مصرف و استفاده حرفه‌ای

موارد مصرف اصلی

  • Moderate xerodermia associated with dermatitis and/or psoriasis
  • Restoration of the normal physiological condition of the dermis
  • Rehydration of skin tissue where cell turnover of the stratum corneum is increased

استفاده حرفه‌ای

Viscoderm 1.6 is a sterile, single-use medical device for intradermal use, to be sold on medical prescription only and administered by intradermal injection by qualified personnel only. It is injected at ambient temperature under strict aseptic conditions, intradermally at medium-deep level using a linear or picotage technique, with the 30G x 1/2 inch (0.3 x 12 mm) needle included in the kit. The recommended posology is an initial cycle of three treatment sessions at one-week intervals, possibly followed by monthly maintenance sessions. Because the 1.5 ml pre-filled syringe allows a whole session to be completed with a single syringe, it is advisable to replace the needle halfway through the treatment, for example using two separate needles to treat the whole face. Do not inject intravascularly, into the muscles or tendons, or for breast enlargement. Do not mix with other products, and do not mix with disinfectants such as quaternary ammonium salts or chlorhexidine, as a precipitate may form. The content of the pre-filled syringe is sterile and the outer surface of the syringe is not; do not use after the expiry date or if the packaging is open or damaged. Do not re-sterilise and do not reuse. Once opened, use immediately and discard after use.

نواحی درمان

  • Intradermal administration, at medium-deep level
  • The treating practitioner determines the area treated

مشخصات بیمار

Viscoderm 1.6 is indicated for adults of both sexes. The device restores the normal physiological condition of the dermis in cases of xerodermia related to dermatitis and/or psoriasis, and the 1.6% concentration is indicated to counteract moderate xerodermia. Suitability is determined by the treating practitioner. The injection site must be on healthy skin. It must not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components of the product. It must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling, and must not be injected into areas where inflammatory processes are present.

نحوه عملکرد Viscoderm 1.6 ​

Viscoderm 1.6 delivers highly purified sodium hyaluronate, obtained by fermentation and not subjected to chemical modification processes, directly into the dermis. The viscoelastic and moisturising properties of hyaluronic acid, combined with the possibility of maintaining it at adequate levels in the skin tissues, rehydrate the tissues and create the optimal conditions to prevent and combat the process of dry skin, favouring tissue remodelling. Intradermal administration restores the physiological quantity of hyaluronic acid in the treated tissues. At a molecular weight of about 1 million Dalton, very close to the natural molecular weight of endogenous hyaluronic acid, the product is totally biocompatible. The 1.6% concentration is the mid concentration of the three in the range and is the one indicated for moderate xerodermia.

چرا از Allpara سفارش دهید

Allpara محصولات VISCODERM اصل و تأییدشده را با قابلیت ردیابی کامل سری ساخت، موجودی دارای گواهی CE، ارسال سریع در سراسر اتحادیه اروپا و پشتیبانی تخصصی پس از فروش ارائه می‌دهد.

پرسش‌های متداول

How does Viscoderm 1.6 differ from Viscoderm 0.8 and 2.0?

The three concentrations share one intended use and differ by the degree of xerodermia they address. Viscoderm 0.8 (8 mg/1 ml) is indicated to counteract slight xerodermia, Viscoderm 1.6 (24 mg/1.5 ml, equivalent to 16 mg/ml) moderate xerodermia, and Viscoderm 2.0 (20 mg/1 ml) severe xerodermia.

Is the hyaluronic acid in Viscoderm 1.6 chemically modified?

No. The hyaluronic acid is obtained by fermentation and has not undergone chemical modification processes, which results in excellent tolerability. It is highly purified, with a molecular weight of about 1 million Dalton, very close to that of endogenous hyaluronic acid, making the product totally biocompatible.

Who should not be treated with Viscoderm 1.6?

Viscoderm 1.6 must not be used in conjunction with treatments such as laser resurfacing and medium-deep peeling. It must also not be used in pregnant or breast-feeding women, in patients with autoimmune diseases, or in cases of known hypersensitivity or allergy to the components, and the injection site must be on healthy skin and free of inflammatory processes.

محصولات بیشتر از IBSA

مشاهده آزمایشگاه ←
* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.